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Application of single-use technologies in biopharmaceutical manufacturing can be driven by several factors such 
as reduced capital costs, reduced risk of cross-contamination, increased process flexibility, and reduced 
cleaning validation. However, implementation of single-use technologies have been restricted due to a number 
of concerns, with the most commonly cited being the presence of extractables and leachables (E/L) from single-
use technologies. In general, overly conservative estimates of E/L are used in the risk assessment due to lack of 
data on clearance, resulting in a time-consuming, costly, and extensive E/L assessment for single-use 
technologies.  
 
A proof-of-concept study is presented here to simplify these E/L assessments for qualification and 
implementation of single-use technologies in biopharmaceutical manufacturing. Results from the study indicated 
clearance of defined E/L in protein solutions. However, unexpected clearance phenomena were observed for 
specific groups of E/L, which will be discussed in detail.    
 
